Kalindi Mehta

Suggest Changes
Learn More
BACKGROUND A major obstacle to the administration of highly active antiretroviral therapy (HAART) in resource-limited settings is the high cost of CD4 count testing. The total lymphocyte count (TLC)(More)
  • 1